SCHEMBL6424264

SCHEMBL6424264

CN(C(=O)C1CCC1)c1ccc(Cl)cc1

nearest known ligand 0.56

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
PDK2 Q15119 5/20 0.56
CNR2 P34972 1/20 0.50
HSD17B1 P14061 1/20 0.49
HSD17B2 P37059 1/20 0.49
GAA P10253 3/20 0.45
HPGD P15428 1/20 0.45
SMN1; SMN2 Q16637 1/20 0.45
RAB9A P51151 1/20 0.45
INSR P06213 1/20 0.42
ITK Q08881 1/20 0.42
FASN P49327 1/20 0.42
GPBAR1 Q8TDU6 1/20 0.41
POLB P06746 2/20 0.40
KMT2A Q03164 2/20 0.40
MEN1 O00255 1/20 0.40
NPC1 O15118 1/20 0.40
ALDH1A1 P00352 1/20 0.40
TDP1 Q9NUW8 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5086341 0.95 CNR2 (0.56) PDK2CNR2HSD17B1HSD17B2GAA
SCHEMBL3916812 0.93 PDK2 (0.59) PDK2CNR2HSD17B1HSD17B2FASN
SCHEMBL11938472 0.85 PKM (0.47) PDK2CNR2RAB9AITKFASN
Hydrochloric Acid SCHEMBL19520341 0.84 PDK2 (0.52) PDK2CNR2HSD17B1HSD17B2KMT2A
SCHEMBL22624637 0.84 PDK2 (0.62) PDK2HSD17B1HSD17B2POLB
SCHEMBL19520529 0.82 PDK2 (0.66) PDK2HSD17B1HSD17B2SMN1; SMN2KMT2A
SCHEMBL6422688 0.79 CNR2 (0.47) PDK2CNR2GAAHPGDSMN1; SMN2
SCHEMBL1749860 0.78 SRD5A2 (0.50) PDK2ITKFASNPOLBKMT2A
SCHEMBL5085953 0.78 MLNR (0.49) PDK2CNR2RAB9AFASNNPC1
SCHEMBL8819827 0.77 PKM (0.59) HPGDSMN1; SMN2RAB9AFASNPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1532122-A1 11-BETA-HYDROXYSTEROID DEHYDROGENASE 1 INHIBITORS USEFUL FOR THE TREATMENT OF DIABETES, OBESITY AND DYSLIPIDEMIA Merck & Co., Inc. (US) 2005-05-25 EP disclosed
WO-2003104208-A1 11-BETA-HYDROXYSTEROID DEHYDROGENASE 1 INHIBITORS USEFUL FOR THE TREATMENT OF DIABETES, OBESITY AND DYSLIPIDEMIA MERCK & CO., INC. (US) 2003-12-18 WO disclosed